CN1240426C - Prepared Chinese medicine for treating ulcerative stomatitis - Google Patents

Prepared Chinese medicine for treating ulcerative stomatitis Download PDF

Info

Publication number
CN1240426C
CN1240426C CN 02121334 CN02121334A CN1240426C CN 1240426 C CN1240426 C CN 1240426C CN 02121334 CN02121334 CN 02121334 CN 02121334 A CN02121334 A CN 02121334A CN 1240426 C CN1240426 C CN 1240426C
Authority
CN
China
Prior art keywords
parts
chinese patent
portions
patent medicine
ulcer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 02121334
Other languages
Chinese (zh)
Other versions
CN1463730A (en
Inventor
梁风军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02121334 priority Critical patent/CN1240426C/en
Publication of CN1463730A publication Critical patent/CN1463730A/en
Application granted granted Critical
Publication of CN1240426C publication Critical patent/CN1240426C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention discloses a Chinese patent medicine for treating oral ulcers and aims to provide a Chinese patent medicine for treating oral ulcers, which has high therapeutic effect and remote possibility of relapse. The Chinese patent medicine comprises raw materials of traditional Chinese medicines proportioned according to parts by weight: 8 to 12 portions of dryobalanops aromatica, 90 to 110 portions of sodium borate, 3 to 7 portions of folium phyllostachytis, 40 to 60 portions of plaster, 8 to 12 portions of gypsum rubrum and 3 to 8 portions of natural indigo. The Chinese patent medicine is nontoxic and innocuous to human bodies and convenient to take without being decocted; the Chinese patent medicine treats both manifestations and root cause of diseases with an obvious clinical curative effect, and the effective rate reaches 79.53%.

Description

The Chinese patent medicine of treatment oral ulcer
Technical field
The present invention relates to Chinese patent medicine, particularly relate to the Chinese patent medicine for the treatment of oral ulcer, aphtha, erosion of the oral mucosa, stomatitis.
Technical background
Oral ulcer is the commonly encountered diseases of department of eye, its ulcer is mainly in positions such as oral mucosa, lip, tongue, gingiva, pharynx, larynx, has in batches the characteristics of outbreak repeatedly, and at present main Therapeutic Method is to take multivitamin, severe patient is taken hormone therapy, and curative effect can not be satisfactory.
Summary of the invention
Purpose of the present invention aims to provide a kind of curative effect height, is difficult for the Chinese patent medicine of the treatment oral ulcer of recurrence.
Solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to oral ulcer, from motherland's medical treasure-house, filter out invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, and antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out damp and hot Chinese patent medicine clearly, makes oral Chinese patent medicine by traditional Chinese medical science prescription theory.
Chinese patent medicine of the present invention is characterized in that: raw material of Chinese medicine and weight amount proportioning:
8~12 parts of Borneolum Syntheticums
90~110 parts of Boraxs
3~7 parts on Folium Bambusae
40~60 parts in Gypsum Fibrosum
8~12 parts of Mirabilitum crystallinas
3~8 parts of Indigo Naturaliss
Above-mentioned weight portion proportioning raw material of Chinese medicine is ground into powder, is coated with use outward.
Optimum weight part proportioning of the present invention is:
10 parts of Borneolum Syntheticums
100 parts of Boraxs
5 parts on Folium Bambusae
50 parts in Gypsum Fibrosum
10 parts of Mirabilitum crystallinas
5 parts of Indigo Naturaliss
Above-mentioned Chinese medicinal raw materials in portion by weight is pressed into lamellar, sucks use.
It is considered herein that oral ulcer is many because of long-pending on the heart-fire, spleen-heat is wet contains, hyperactivity of fire caused by deficiency of YIN is fumigated in mouth, the corruption of intenseness of heat meat, due to the immunologic hypofunction, to the untimely treatment of oral ulcer, easy concurrent behcets disease, therefore should be with invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, and antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling are let out the damp and hot principles of formulating prescriptions that are clearly.
Borneolum Syntheticum, Borax are gone into heart channel in the side, open stifled key, disperse pathogenic fire, the heat-clearing and toxic substances removing antiinflammatory, and Indigo Naturalis is gone into Liver Channel, heart gastric heat, removing summer-heat is scorchingly hot, the removing heat from blood throat, Folium Bambusae, Gypsum Fibrosum clearing heat and relieving fidgetness promote ulcer healing, Mirabilitum crystallina is driven away heat after the vital organs of the human body to help.
For showing Chinese patent medicine of the present invention to oral cavity ulcer treatment effect, the present invention has carried out system's clinical observation to 298 routine intractable oral cavity ulcers, and its curative effect statistical result is as follows:
Contrast before and after the treatment of table 1 oral ulcer
Symptom Before the treatment After the treatment
Symptom is arranged Mild symptoms The symptom no change Sx Effective percentage (%)
The sticking mucosal ulcer of repeated relapsing aphtha gingiva buccal mucosa ulcer Mucosa of lip ulcer periglottis ulcer pharyngolaryngeal mucosa ulcer 298 242 292 248 86 152 237 201 256 216 80 140 61 41 36 32 6 12 0 0 0 0 0 0 75.93 83.4 87.67 87.10 93.02 92.11
Wherein intractable oral cavity ulcer age of onset reckling is 3 years old, and the maximum 70 years old sick is sent out history (discovery oral ulcer) half a year---and 20 years, male's 116 examples, women's 182 examples.
Show that from above-mentioned clinical statistics data Chinese patent medicine of the present invention is to disease controlling, alleviate patient's symptom and the complication effect is obvious.
The present invention has following advantage:
1, to select natural Chinese medicinal herb for use be raw material in the present invention, each component meets the pharmaceutical control law regulation, and full side's compatibility has invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, let out damp and hot effect clearly, meet the traditional Chinese medical science the pathogenetic understanding of oral ulcer, and nontoxic to human body.
2, the present invention need not decoct taking convenience.
3, treating both the principal and secondary aspects of a disease of the present invention, clinical efficacy is remarkable, and effective percentage reaches 79.53%.
The specific embodiment
Embodiment 1:
Getting raw material of Chinese medicine and weight proportion is:
Borneolum Syntheticum 10g, Borax 100g, Folium Bambusae 5g, Gypsum Fibrosum 50g, Mirabilitum crystallina 10g, Indigo Naturalis 5g.
Manufacture method: above-mentioned Chinese medicine is chosen the decontamination choosing only earlier, oven dry is ground into fine powder, sieves, and fully mixing is squeezed into lamellar and gets final product.Or put into capsule 2-3 and preserve good.
Function with cure mainly: invigorating the spleen and benefiting QI, the detoxifcation hold back skin ulcer, be used for recurrent oral ulceration, mucosal ulcer such as tongue, cheek, lip, pharynx, larynx, gum.
Usage and consumption: suck an a slice, six times on the one.
Specification: every 0.1g on chip.
Storage: sealing, put shady and cool place.
Embodiment 2:
Getting raw material of Chinese medicine and weight proportion is:
Borneolum Syntheticum 8g, Borax 90g, Folium Bambusae 3g, Gypsum Fibrosum 40g, Mirabilitum crystallina 8g, Indigo Naturalis 3g.
The Chinese patent medicine raw material of above-mentioned weight proportion is ground to form powdery, be coated with use outward.
Embodiment 3:
Getting Chinese ready made herbal medicine raw material and weight proportion is:
Borneolum Syntheticum 12g, Borax 110g, Folium Bambusae 7g, Gypsum Fibrosum 60g, Mirabilitum crystallina 12g, Indigo Naturalis 8g.
Above-mentioned Chinese medicine raw materials by weight proportion is ground to form powdery, be coated with use outward.

Claims (2)

1, a kind ofly treat the Chinese patent medicine that the oral ulcer powdery is coated with outward, it is characterized in that: raw material of Chinese medicine and weight portion proportioning:
8~12 parts of Borneolum Syntheticums,
90~110 parts of Boraxs,
3~7 parts on Folium Bambusae,
40~60 parts in Gypsum Fibrosum,
8~12 parts of Mirabilitum crystallinas,
3~8 parts of Indigo Naturaliss.
2, a kind ofly treat the Chinese patent medicine that the oral ulcer lamellar is sucked, it is characterized in that described raw material of Chinese medicine weight portion proportioning:
10 parts of Borneolum Syntheticums,
100 parts of Boraxs,
5 parts on Folium Bambusae,
50 parts in Gypsum Fibrosum,
10 parts of Mirabilitum crystallinas,
5 parts of Indigo Naturaliss.
CN 02121334 2002-06-14 2002-06-14 Prepared Chinese medicine for treating ulcerative stomatitis Expired - Fee Related CN1240426C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02121334 CN1240426C (en) 2002-06-14 2002-06-14 Prepared Chinese medicine for treating ulcerative stomatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02121334 CN1240426C (en) 2002-06-14 2002-06-14 Prepared Chinese medicine for treating ulcerative stomatitis

Publications (2)

Publication Number Publication Date
CN1463730A CN1463730A (en) 2003-12-31
CN1240426C true CN1240426C (en) 2006-02-08

Family

ID=29742925

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02121334 Expired - Fee Related CN1240426C (en) 2002-06-14 2002-06-14 Prepared Chinese medicine for treating ulcerative stomatitis

Country Status (1)

Country Link
CN (1) CN1240426C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396315C (en) * 2005-12-02 2008-06-25 钟荣权 Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis
CN101194994B (en) * 2007-12-11 2011-09-21 叶志群 Externally used medicament for treating toothache
CN104721297A (en) * 2015-04-07 2015-06-24 四川双鑫生物科技有限公司 Powder medicament for treating oral candidiasis and preparation method of powder medicament

Also Published As

Publication number Publication date
CN1463730A (en) 2003-12-31

Similar Documents

Publication Publication Date Title
CN101066445A (en) Chinese medicine prepn for curing gastropathy radically
CN1723931A (en) Cure-all ointment for treating burns and scald
CN1627951A (en) Compositions and method for prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
CN1679745A (en) External-applied medicine for treating burn, valnus and local tumor inflammation
CN101204529A (en) Medicine for wound-curing and scar-dispeling
CN1864733A (en) Chinese proprietary medicine for treating oral cavity inflammation
CN1240426C (en) Prepared Chinese medicine for treating ulcerative stomatitis
CN1089002C (en) Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease
CN1165335C (en) Compound preparation for curing diarrhea
CN1259052C (en) Medicinal composition for treating burn and scald and preparing method
CN1078468C (en) Health-care products composition
CN1296034C (en) Halitosis removing toothpaste
CN1579497A (en) Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method
CN1192365A (en) Traditional Chinese medicine for treating mastosis
CN1076864A (en) Skin health-care liquid
CN1140275C (en) Quick-acting powdered medicine for treating stomatopathy
CN1098299A (en) The sweet cool Kouchuang powder for curing aphthosis and the compound method thereof that are used for recurrent aphtha and all kinds of aphthas
CN1255174C (en) Power of pasting on umbilicus for treating dianhea and abdominal pain of infants
CN1160083C (en) Medicine for treating osteomyelitis and lymphoid tuberculosis, and making process thereof
CN106552134A (en) A kind of Chinese medicinal formulae for treating periodontal disease
CN1228313A (en) Tonifying Yang anticancer powder for alimentary canal
CN112494615A (en) Traditional Chinese medicine composition, preparation method thereof, oral medicament and application
CN104906542A (en) Traditional Chinese medicine composition for treating canine coronavirus infection and preparation method of traditional Chinese medicine composition
CN109078034A (en) A kind of drug for treating canker sore
CN1448154A (en) Medicine for treating exopathic disease and preparation process thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060208